Zrepag MF 1mg/500mg Tablet
Marketer
Daylon Healthcare
Salt Composition
Repaglinide (1mg) + Metformin (500mg)
Overview Zrepag MF 1mg/500mg Tablet
Combiflora 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Combiflora with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue this medication, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect; learn to recognize its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular mealtimes and carry a readily available glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; it may be unsuitable. Consult your physician prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring is crucial, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of Zrepag MF 1mg/500mg Tablet
No text provided to rephrase.
Uses of Zrepag MF 1mg/500mg Tablet
Managing Type 2 Diabetes
Major Benefits of Zrepag MF 1mg/500mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zrepag MF 1mg/500mg Tablets should be administered with a meal.
Common Side effects of Zrepag MF 1mg/500mg Tablet:
- Hypoglycemia (low blood glucose level)
- Sweating
- Dizziness
- Diarrhea
- Loss of appetite
- Nausea
- Stomach pain
- Taste change
- Weight gain
How to use Zrepag MF 1mg/500mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Zrepag MF 1mg/500mg tablets with a meal.
How Zrepag MF 1mg/500mg Tablet works:
Each Zrepag MF tablet (1mg/500mg) combines two distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zrepag MF 1mg/500mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Zrepag MF 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
The use of Zrepag MF 1mg/500mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Zrepag MF 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Zrepag MF 1mg/500mg tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Zrepag MF 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiation at a low dose is typical; however, its use is contraindicated in severe liver disease.
What if you forget to take Zrepag MF 1mg/500mg Tablet :
NA
Facts to Know About Zrepag MF 1mg/500mg Tablet
| Label | Value |
|---|---|
| Addictive | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently